User Fee Management System Part Of CDER Plans To Enhance IT Capabilities
This article was originally published in The Pink Sheet Daily
The need to assimilate biosimilar and generic drug user fee programs and a quest for greater efficiency are major drivers of the center’s proposed $88.9 million spending plan on information technology systems in fiscal year 2014.
You may also be interested in...
The Senate Appropriations Committee April 26 approves a $3.9 billion spending plan for the agency in fiscal 2013, providing a $12.5 million boost in Treasury spending over President Obama’s proposed budget, with the extra funds slated for the food and animal drug programs.
The agency has not been able to get rid of outdated IT systems despite spending more than $160 million to date on a program designed to do that among other goals.
Industry also seems supportive of the idea, while Pew touts the power of the power of track-and-trace as a deterrent.